Information Journal Paper
APA:
Copy. (2017). ESCITALOPRAM VERSUS PAROXETINE CONTROLLED RELEASE IN MAJOR DEPRESSIVE DISORDER: A RANDOMIZED TRIAL. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 13(-), 117-117. SID. https://sid.ir/paper/729237/en
Vancouver:
Copy. ESCITALOPRAM VERSUS PAROXETINE CONTROLLED RELEASE IN MAJOR DEPRESSIVE DISORDER: A RANDOMIZED TRIAL. NEUROPSYCHIATRIC DISEASE AND TREATMENT[Internet]. 2017;13(-):117-117. Available from: https://sid.ir/paper/729237/en
IEEE:
Copy, “ESCITALOPRAM VERSUS PAROXETINE CONTROLLED RELEASE IN MAJOR DEPRESSIVE DISORDER: A RANDOMIZED TRIAL,” NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. 13, no. -, pp. 117–117, 2017, [Online]. Available: https://sid.ir/paper/729237/en